Local anesthetic and opioid analgesic combination

1 marketed 1 in Phase 3

This page covers all Local anesthetic and opioid analgesic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (lidocaine); mu opioid receptor (sufentanil).

Targets

Voltage-gated sodium channels (lidocaine); mu opioid receptor (sufentanil)

Marketed (1)

Phase 3 pipeline (1)